Opioid Addiction and Prescribing: The Latest Updates for the Pediatric-focused APRN
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hour, of which 0.25 is pharmacology and 0.25 controlled substance.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2019 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Describe the epidemiology of opioid addiction in pediatric and adolescent patients.
- Identify opioid prescribing and stewardship practices that contribute to a reduction in opioid addiction and misuse.
- Relate the role of pediatric-focused APRNs in prescribing medication-assisted treatment to patient outcomes.
- Discuss federal policies, fiscal and ethical influences on prescribing schedule II controlled substances.
Kristin Hittle Gigli, PhD, RN, CPNP-AC, CCRN: Postdoctoral research fellow, University of Pittsburgh, School of Medicine, Department of Critical Care, Pittsburgh
Dr. Hittle Gigli has no relevant financial relationships to disclose.
- 1.00 Contact hours